Biotechnology Market (Biopharmacy, Bioservices, Bioagriculture, Bioindustrial, Fermentation, DNA sequencing, Tissue Engineering, Regeneration) Analysis And Segment Forecasts To 2020
The global market for biotechnology is expected to reach USD 604.40 billion by 2020. Increasing application scope coupled with the rising demand for effective vaccines and drugs in an attempt to improve healthcare access to patients with unmet medical needs is expected to drive market demand over the next six years. In addition, the need to enhance agricultural productivity via the use of genetically engineered seeds is expected to serve this market as a driver.
Biopharmacy dominated the overall market, accounting for over 60% of the total revenue in 2013. High costs associated with the drug discovery process coupled with increasing healthcare expenditures in emerging markets such as India, China and Brazil are some of the factors augmenting biopahrmacy growth. Growing popularity of contract research outsourcing (CRO) services in an attempt to curb manufacturing and R&D costs are expected to drive bioservices demand, which is expected to be the fastest growing application market for biotechnology..
Further key findings from the study suggest:
North America was the largest regional market, accounting for over 40% of global revenue in 2013, with growth being driven by the presence of sophisticated healthcare infrastructure, high patient awareness levels and healthcare expenditure.
Asia Pacific is expected to register the fastest CAGR of 14.8% during the forecast period owing to the presence of untapped opportunities in emerging markets such as India and China.
Tissue engineering and regeneration technology dominated the market in terms of revenue share in 2013 at 32.5% on account of the rising demand for regenerative medicine.
Key industry participants include Novo Nordisk, Amgen, Gilead Sciences, Celgene, Biogen Idic, Teva Pharmaceutical Industries, Merck KGaA, CSL, Regeneron, Alexion Pharmaceuticals, Shire PLC, Vertex Pharmaceuticals, BioMarin Pharmaceutical, Elan, Actelion, Onyx Pharmaceuticals, Dr. Reddy’s Laboratories, Seattle Genetics, Alkermes, Ariad Pharmaceuticals, Cubist Pharmaceuticals, United Therapeutics, Ipsen Group and DiaSorin.
For the purpose of this study, Grand View Research has segmented the global biotechnology market on the basis of application and region:
Biopharmacy dominated the overall market, accounting for over 60% of the total revenue in 2013. High costs associated with the drug discovery process coupled with increasing healthcare expenditures in emerging markets such as India, China and Brazil are some of the factors augmenting biopahrmacy growth. Growing popularity of contract research outsourcing (CRO) services in an attempt to curb manufacturing and R&D costs are expected to drive bioservices demand, which is expected to be the fastest growing application market for biotechnology..
Further key findings from the study suggest:
North America was the largest regional market, accounting for over 40% of global revenue in 2013, with growth being driven by the presence of sophisticated healthcare infrastructure, high patient awareness levels and healthcare expenditure.
Asia Pacific is expected to register the fastest CAGR of 14.8% during the forecast period owing to the presence of untapped opportunities in emerging markets such as India and China.
Tissue engineering and regeneration technology dominated the market in terms of revenue share in 2013 at 32.5% on account of the rising demand for regenerative medicine.
Key industry participants include Novo Nordisk, Amgen, Gilead Sciences, Celgene, Biogen Idic, Teva Pharmaceutical Industries, Merck KGaA, CSL, Regeneron, Alexion Pharmaceuticals, Shire PLC, Vertex Pharmaceuticals, BioMarin Pharmaceutical, Elan, Actelion, Onyx Pharmaceuticals, Dr. Reddy’s Laboratories, Seattle Genetics, Alkermes, Ariad Pharmaceuticals, Cubist Pharmaceuticals, United Therapeutics, Ipsen Group and DiaSorin.
For the purpose of this study, Grand View Research has segmented the global biotechnology market on the basis of application and region:
- Biotechnology Application Outlook
- Medical Gases
- BioPharmacy
- BioServices
- BioAgriculture
- BioIndustrial
- Biotechnology Technology Outlook
- Fermentation
- Tissue engineering and Regeneration
- PCR Tehnology
- Nanobiotechnology
- Chromatography Market
- DNA Sequencing
- Cell Based Assay
- Others
- Biotechnology Regional Outlook
- North America
- Europe
- Asia Pacific
- RoW
CHAPTER 1. EXECUTIVE SUMMARY
1.1. Biotechnology – Industry Summary and Critical Success Factors (CSFs)
CHAPTER 2. BIOTECHNOLOGY INDUSTRY OUTLOOK
2.1. Market Segmentation
2.2. Market Size and Growth Prospects
2.3. Biotechnology Market Dynamics
2.3.1. Market Driver Analysis
2.3.2. Market Restraint Analysis
2.4. Key Opportunities Prioritized
2.5. Industry Analysis - Porter's
2.6. Biotechnology - Company Market Share Analysis
2.7. Biotechnology Market PESTEL Analysis, 2013
CHAPTER 3. BIOTECHNOLOGY TECHNOLOGY OUTLOOK
3.1. Fermentation
3.1.1. Global fermentation based Biotechnology market demand, (USD Billion), 2012 – 2020
3.2. Tissue Engineering and Regeneration
3.2.1. Global tissue engineering and regeneration based Biotechnology market demand, (USD Billion), 2012 – 2020
3.3. PCR Technology
3.3.1. Global PCR technology based Biotechnology market demand, (USD Billion), 2012 – 2020
3.4. Nanobiotechnology
3.4.1. Global nanobiotechnology based Biotechnology market demand, (USD Billion), 2012 – 2020
3.5. Chromatography
3.5.1. Global chromatography based Biotechnology market demand, (USD Billion), 2012 – 2020
3.6. DNA Sequencing
3.6.1. Global DNA sequencing market demand, (USD Billion), 2012 – 2020
3.7. Cell based Array
3.7.1. Global cell based array Biotechnology market demand, (USD Billion), 2012 – 2020
3.8. Others
3.8.1. Global other technology based Biotechnology market demand, (USD Billion), 2012 – 2020
CHAPTER 4. BIOTECHNOLOGY APPLICATION OUTLOOK
4.1. Biopharmacy
4.1.1. Global Biotechnology demand in Biopharmacy applications by region, 2012 – 2020 (USD Billion)
4.2. Bioservices
4.2.1. Global Biotechnology demand in Bioservices applications by region, 2012 – 2020 (USD Billion)
4.3. Bioagriculture
4.3.1. Global Biotechnology demand in Bioagriculture applications by region, 2012 – 2020 (USD Million)
4.4. Bioindustrial
4.4.1. Global Biotechnology demand in bioindustrial applications by region, 2012 – 2020 (USD Billion)
CHAPTER 5. BIOTECHNOLOGY REGIONAL OUTLOOK
5.1. North America
5.1.1. North America Biotechnology market revenue by application, (USD Billion), 2012 – 2020
5.2. Europe
5.2.1. Europe Biotechnology market revenue by application, (USD Billion), 2012 - 2020
5.3. Asia Pacific
5.3.1. Asia Pacific Biotechnology market revenue by application, (USD Billion), 2012 - 2020
5.4. RoW
5.4.1. RoW Biotechnology market revenue by application, (USD Billion), 2012 – 2020
CHAPTER 6. COMPETITIVE LANDSCAPE
6.1 Abbott Laboratories
6.1.1 Company Overview
6.1.2 Financial Performance
6.1.3 Product Benchmarking
6.1.4 Strategic Initiatives
6.2 Amgen Inc.
6.2.1 Company Overview
6.2.2 Financial Performance
6.2.3 Product Benchmarking
6.2.4 Strategic Initiatives
6.3 Johnson and Johnson
6.3.1 Company Overview
6.3.2 Financial Performance
6.3.3 Product Benchmarking
6.3.4 Strategic Initiatives
6.4 Merck
6.4.1 Company Overview
6.4.2 Financial Performance
6.4.3 Product Benchmarking
6.4.4 Strategic Initiatives
6.5 Novo Nordisk
6.5.1 Company Overview
6.5.2 Financial Performance
6.5.3 Product Benchmarking
6.5.4 Strategic Initiatives
6.6 Novartis
6.6.1 Company Overview
6.6.2 Financial Performance
6.6.3 Product Benchmarking
6.6.4 Strategic Initiatives
6.7 Pfizer
6.7.1 Company Overview
6.7.2 Financial Performance
6.7.3 Product Benchmarking
6.7.4 Strategic Initiatives
6.8 Roche
6.8.1 Company Overview
6.8.2 Financial Performance
6.8.3 Product Benchmarking
6.8.4 Strategic Initiatives
6.9 Sanofi Aventis
6.9.1 Company Overview
6.9.2 Financial Performance
6.9.3 Product Benchmarking
6.9.4 Strategic Initiatives
6.10 Lonza Group
6.10.1 Company Overview
6. 10.2 Financial Performance
6. 10.3 Product Benchmarking
6. 10.4 Strategic Initiatives
6.11 Biogen Idec Inc.
6.11.1 Company Overview
6. 11.2 Financial Performance
6. 11.3 Product Benchmarking
6. 11.4 Strategic Initiatives
6.12 Astra Zeneca
6.12.1 Company Overview
6. 12.2 Financial Performance
6. 12.3 Product Benchmarking
6. 12.4 Strategic Initiatives
6.13 Genentech
6.13.1 Company Overview
6. 13.2 Financial Performance
6. 13.3 Product Benchmarking
6. 13.4 Strategic Initiatives
6.14 Genzyme
6.14.1 Company Overview
6. 14.2 Financial Performance
6. 14.3 Product Benchmarking
6. 14.4 Strategic Initiatives
6.15 Gilead Sciences
6.15.1 Company Overview
6. 15.2 Financial Performance
6. 15.3 Product Benchmarking
6. 15.4 Strategic Initiatives
6.16 Celgene
6.16.1 Company Overview
6. 16.2 Financial Performance
6. 16.3 Product Benchmarking
6. 16.4 Strategic Initiatives
CHAPTER 7. METHODOLOGY AND SCOPE
7.1. Research Methodology
7.2. Research Scope & Assumption
7.3. List of Data Sources
1.1. Biotechnology – Industry Summary and Critical Success Factors (CSFs)
CHAPTER 2. BIOTECHNOLOGY INDUSTRY OUTLOOK
2.1. Market Segmentation
2.2. Market Size and Growth Prospects
2.3. Biotechnology Market Dynamics
2.3.1. Market Driver Analysis
2.3.2. Market Restraint Analysis
2.4. Key Opportunities Prioritized
2.5. Industry Analysis - Porter's
2.6. Biotechnology - Company Market Share Analysis
2.7. Biotechnology Market PESTEL Analysis, 2013
CHAPTER 3. BIOTECHNOLOGY TECHNOLOGY OUTLOOK
3.1. Fermentation
3.1.1. Global fermentation based Biotechnology market demand, (USD Billion), 2012 – 2020
3.2. Tissue Engineering and Regeneration
3.2.1. Global tissue engineering and regeneration based Biotechnology market demand, (USD Billion), 2012 – 2020
3.3. PCR Technology
3.3.1. Global PCR technology based Biotechnology market demand, (USD Billion), 2012 – 2020
3.4. Nanobiotechnology
3.4.1. Global nanobiotechnology based Biotechnology market demand, (USD Billion), 2012 – 2020
3.5. Chromatography
3.5.1. Global chromatography based Biotechnology market demand, (USD Billion), 2012 – 2020
3.6. DNA Sequencing
3.6.1. Global DNA sequencing market demand, (USD Billion), 2012 – 2020
3.7. Cell based Array
3.7.1. Global cell based array Biotechnology market demand, (USD Billion), 2012 – 2020
3.8. Others
3.8.1. Global other technology based Biotechnology market demand, (USD Billion), 2012 – 2020
CHAPTER 4. BIOTECHNOLOGY APPLICATION OUTLOOK
4.1. Biopharmacy
4.1.1. Global Biotechnology demand in Biopharmacy applications by region, 2012 – 2020 (USD Billion)
4.2. Bioservices
4.2.1. Global Biotechnology demand in Bioservices applications by region, 2012 – 2020 (USD Billion)
4.3. Bioagriculture
4.3.1. Global Biotechnology demand in Bioagriculture applications by region, 2012 – 2020 (USD Million)
4.4. Bioindustrial
4.4.1. Global Biotechnology demand in bioindustrial applications by region, 2012 – 2020 (USD Billion)
CHAPTER 5. BIOTECHNOLOGY REGIONAL OUTLOOK
5.1. North America
5.1.1. North America Biotechnology market revenue by application, (USD Billion), 2012 – 2020
5.2. Europe
5.2.1. Europe Biotechnology market revenue by application, (USD Billion), 2012 - 2020
5.3. Asia Pacific
5.3.1. Asia Pacific Biotechnology market revenue by application, (USD Billion), 2012 - 2020
5.4. RoW
5.4.1. RoW Biotechnology market revenue by application, (USD Billion), 2012 – 2020
CHAPTER 6. COMPETITIVE LANDSCAPE
6.1 Abbott Laboratories
6.1.1 Company Overview
6.1.2 Financial Performance
6.1.3 Product Benchmarking
6.1.4 Strategic Initiatives
6.2 Amgen Inc.
6.2.1 Company Overview
6.2.2 Financial Performance
6.2.3 Product Benchmarking
6.2.4 Strategic Initiatives
6.3 Johnson and Johnson
6.3.1 Company Overview
6.3.2 Financial Performance
6.3.3 Product Benchmarking
6.3.4 Strategic Initiatives
6.4 Merck
6.4.1 Company Overview
6.4.2 Financial Performance
6.4.3 Product Benchmarking
6.4.4 Strategic Initiatives
6.5 Novo Nordisk
6.5.1 Company Overview
6.5.2 Financial Performance
6.5.3 Product Benchmarking
6.5.4 Strategic Initiatives
6.6 Novartis
6.6.1 Company Overview
6.6.2 Financial Performance
6.6.3 Product Benchmarking
6.6.4 Strategic Initiatives
6.7 Pfizer
6.7.1 Company Overview
6.7.2 Financial Performance
6.7.3 Product Benchmarking
6.7.4 Strategic Initiatives
6.8 Roche
6.8.1 Company Overview
6.8.2 Financial Performance
6.8.3 Product Benchmarking
6.8.4 Strategic Initiatives
6.9 Sanofi Aventis
6.9.1 Company Overview
6.9.2 Financial Performance
6.9.3 Product Benchmarking
6.9.4 Strategic Initiatives
6.10 Lonza Group
6.10.1 Company Overview
6. 10.2 Financial Performance
6. 10.3 Product Benchmarking
6. 10.4 Strategic Initiatives
6.11 Biogen Idec Inc.
6.11.1 Company Overview
6. 11.2 Financial Performance
6. 11.3 Product Benchmarking
6. 11.4 Strategic Initiatives
6.12 Astra Zeneca
6.12.1 Company Overview
6. 12.2 Financial Performance
6. 12.3 Product Benchmarking
6. 12.4 Strategic Initiatives
6.13 Genentech
6.13.1 Company Overview
6. 13.2 Financial Performance
6. 13.3 Product Benchmarking
6. 13.4 Strategic Initiatives
6.14 Genzyme
6.14.1 Company Overview
6. 14.2 Financial Performance
6. 14.3 Product Benchmarking
6. 14.4 Strategic Initiatives
6.15 Gilead Sciences
6.15.1 Company Overview
6. 15.2 Financial Performance
6. 15.3 Product Benchmarking
6. 15.4 Strategic Initiatives
6.16 Celgene
6.16.1 Company Overview
6. 16.2 Financial Performance
6. 16.3 Product Benchmarking
6. 16.4 Strategic Initiatives
CHAPTER 7. METHODOLOGY AND SCOPE
7.1. Research Methodology
7.2. Research Scope & Assumption
7.3. List of Data Sources
LIST OF TABLES
Biotechnology – Industry Summary & Critical Success Factors (CSFs)
Global Biotechnology market (USD Billion), 2012 - 2020
Global Biotechnology market by region (USD Billion), 2012 – 2020
Global Biotechnology market by technology (USD Billion), 2012 – 2020
Global Biotechnology market by application (USD Billion), 2012 – 2020
Global Fermentation based Biotechnology demand (USD Billion), 2012 – 2020
Global Tissue Engineering and Regeneration Biotechnology demand, (USD Billion), 2012 – 2020
Global PCR Technology based Biotechnology demand (USD Billion), 2012 – 2020
Global Nanobiotechnology based Biotechnology demand, (USD Billion), 2012 – 2020
Global Chromatography based Biotechnology demand (USD Billion), 2012 – 2020
Global DNA Sequencing based Biotechnology demand (USD Billion), 2012 – 2020
Global Cell based Array based Biotechnology demand (USD Billion), 2012 – 2020
Global other technology based Biotechnology demand (USD Billion), 2012 – 2020
Global Biotechnology demand in BioPharmacy applications, (USD Billion), 2012 – 2020
Global Biotechnology demand in BioPharmacy applications, by region, (USD Billion), 2012 – 2020
Global Biotechnology demand in BioServices applications (USD Billion), 2012 – 2020
Global Biotechnology demand in BioServices applications, by region, (USD Billion), 2012 – 2020
Global Biotechnology demand in BioAgriculture applications (USD Billion), 2012 – 2020
Global Biotechnology demand in BioAgriculture applications, by region, (USD Billion), 2012 – 2020
Global Biotechnology demand in BioIndustrial applications (USD Billion), 2012 – 2020
Global Biotechnology demand in BioIndustrial applications, by region, (USD Billion), 2012 – 2020
North America Biotechnology market by application (USD Billion), 2012 – 2020
Europe Biotechnology market by application (USD Billion), 2012 – 2020
Asia Pacific Biotechnology market by application (USD Billion), 2012 – 2020
RoW Biotechnology market by application (USD Billion), 2012 – 2020
Biotechnology – Industry Summary & Critical Success Factors (CSFs)
Global Biotechnology market (USD Billion), 2012 - 2020
Global Biotechnology market by region (USD Billion), 2012 – 2020
Global Biotechnology market by technology (USD Billion), 2012 – 2020
Global Biotechnology market by application (USD Billion), 2012 – 2020
Global Fermentation based Biotechnology demand (USD Billion), 2012 – 2020
Global Tissue Engineering and Regeneration Biotechnology demand, (USD Billion), 2012 – 2020
Global PCR Technology based Biotechnology demand (USD Billion), 2012 – 2020
Global Nanobiotechnology based Biotechnology demand, (USD Billion), 2012 – 2020
Global Chromatography based Biotechnology demand (USD Billion), 2012 – 2020
Global DNA Sequencing based Biotechnology demand (USD Billion), 2012 – 2020
Global Cell based Array based Biotechnology demand (USD Billion), 2012 – 2020
Global other technology based Biotechnology demand (USD Billion), 2012 – 2020
Global Biotechnology demand in BioPharmacy applications, (USD Billion), 2012 – 2020
Global Biotechnology demand in BioPharmacy applications, by region, (USD Billion), 2012 – 2020
Global Biotechnology demand in BioServices applications (USD Billion), 2012 – 2020
Global Biotechnology demand in BioServices applications, by region, (USD Billion), 2012 – 2020
Global Biotechnology demand in BioAgriculture applications (USD Billion), 2012 – 2020
Global Biotechnology demand in BioAgriculture applications, by region, (USD Billion), 2012 – 2020
Global Biotechnology demand in BioIndustrial applications (USD Billion), 2012 – 2020
Global Biotechnology demand in BioIndustrial applications, by region, (USD Billion), 2012 – 2020
North America Biotechnology market by application (USD Billion), 2012 – 2020
Europe Biotechnology market by application (USD Billion), 2012 – 2020
Asia Pacific Biotechnology market by application (USD Billion), 2012 – 2020
RoW Biotechnology market by application (USD Billion), 2012 – 2020
LIST OF FIGURES
Biotechnology Market Segmentation
Global Biotechnology market (USD Billion), 2012 - 2020
Biotechnology value chain analysis
Biotechnology market dynamics
Biotechnology - Company market share analysis, 2013
Key Opportunities Prioritized
Industry Analysis - Porter's
Biotechnology PESTEL Analysis, 2013
Biotechnology market share by technology, 2012 & 2020
Biotechnology market share by application, 2012 & 2020
Global Biotechnology demand in BioPharmacy applications (USD Billion), 2012 – 2020
Global Biotechnology demand in BioServices applications (USD Billion), 2012 – 2020
Global Biotechnology demand in BioAgriculture applications (USD Billion), 2012 – 2020
Global Biotechnology demand in BioIndustrial applications (USD Billion), 2012 – 2020
Biotechnology market share by region, 2012 & 2020
North America Biotechnology market, by application (USD Billion), 2012 – 2020
Europe Biotechnology market, by application (USD Billion), 2012 – 2020
Asia Pacific Biotechnology market, by application (USD Billion), 2012 – 2020
RoW Biotechnology market, by application (USD Billion), 2012 – 2020
Biotechnology Market Segmentation
Global Biotechnology market (USD Billion), 2012 - 2020
Biotechnology value chain analysis
Biotechnology market dynamics
Biotechnology - Company market share analysis, 2013
Key Opportunities Prioritized
Industry Analysis - Porter's
Biotechnology PESTEL Analysis, 2013
Biotechnology market share by technology, 2012 & 2020
Biotechnology market share by application, 2012 & 2020
Global Biotechnology demand in BioPharmacy applications (USD Billion), 2012 – 2020
Global Biotechnology demand in BioServices applications (USD Billion), 2012 – 2020
Global Biotechnology demand in BioAgriculture applications (USD Billion), 2012 – 2020
Global Biotechnology demand in BioIndustrial applications (USD Billion), 2012 – 2020
Biotechnology market share by region, 2012 & 2020
North America Biotechnology market, by application (USD Billion), 2012 – 2020
Europe Biotechnology market, by application (USD Billion), 2012 – 2020
Asia Pacific Biotechnology market, by application (USD Billion), 2012 – 2020
RoW Biotechnology market, by application (USD Billion), 2012 – 2020
